文献速递垂体与肾上腺疾病糖尿病

原发性醛固酮增多症中糖代谢受损与皮质醇共分泌相关

Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本研究对161例新诊断原发性醛固酮增多症患者进行OGTT及库欣筛查,发现77.6%存在至少一项筛查异常,且皮质醇共分泌者T2DM患病率显著高于无共分泌者及匹配对照。

要点

  • 原发性醛固酮增多症患者中皮质醇共分泌常见,与糖代谢受损相关。
  • 地塞米松抑制试验异常者T2DM患病率显著高于正常者及匹配对照。
  • 无自主皮质醇分泌的原醛患者胰岛素抵抗指数也呈升高趋势。

核心结论

  • 自主皮质醇分泌在原醛患者中常见,并与糖代谢受损相关,可能增加T2DM风险。
  • 原醛本身似乎也加重胰岛素抵抗。

研究设计与样本

  • 对德国Conn注册库161例新诊断原醛患者行OGTT及完整库欣筛查(1mg地塞米松抑制试验、午夜唾液皮质醇、24小时尿游离皮质醇)。

主要发现

  • 诊断时125例(77.6%)至少一项库欣筛查试验异常,其中T2DM占6.4%。
  • 地塞米松抑制试验异常者OGTT 2小时血糖显著更高,T2DM患病率20% vs 正常者0.8%(P<0.0001)。
  • 地塞米松抑制试验异常者T2DM患病率20.6% vs KORA对照5.9%(P=0.022)。
  • 无自主皮质醇分泌的原醛患者HOMA-IR较KORA对照呈升高趋势(P=0.05)。

关键数值与推荐

  • 库欣筛查包括1mg地塞米松抑制试验、午夜唾液皮质醇和24小时尿游离皮质醇。
  • T2DM患病率在地塞米松抑制试验异常者为20%,正常者为0.8%(P<0.0001)。
  • 地塞米松抑制试验异常者T2DM患病率20.6% vs KORA对照5.9%(P=0.022)。

临床怎么用

  • 对原醛患者应关注皮质醇共分泌,可考虑进行库欣筛查以评估糖代谢风险。
  • 合并自主皮质醇分泌的原醛患者需更积极筛查和管理T2DM。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and metabolic risks. Recent studies report glucocorticoid cosecretion as a relevant phenotype of PA, which could contribute to associated risks, including type 2 diabetes mellitus (T2DM). The relationship between autonomous cortisol secretion (ACS) and glucose metabolism in PA has not been investigated. OBJECTIVE: To evaluate the prevalence of impaired glucose homeostasis in patients with PA according to cortisol cosecretion. DESIGN: We performed oral glucose tolerance tests (OGTTs) and complete testing for hypercortisolism [1-mg dexamethasone suppression test (DST), late-night salivary cortisol, 24-hour urinary free cortisol] in 161 newly diagnosed patients with PA of the German Conn Registry. Seventy-six of 161 patients were reevaluated at follow-up. We compared our results to a population-based sample from the Cooperative Health Research in the Region of Augsburg (KORA)-F4 study matched to the participants with PA (3:1) by sex, age, and body mass index. RESULTS: At the time of diagnosis, 125 patients (77.6%) had a pathological response in at least one of the Cushing screening tests; T2DM was diagnosed in 6.4% of these 125 cases. Patients with a pathological DST exhibited significantly higher 2-hour plasma glucose in OGTTs and were significantly more often diagnosed with T2DM than were patients with a normal DST (20% vs 0.8%, P < 0.0001) and matched controls from the KORA study (20.6% vs 5.9%, P = 0.022). Patients with PA without ACS tended to have higher homeostatic model assessment of insulin resistance levels than did KORA control subjects (P = 0.05). CONCLUSION: ACS appears frequently in patients with PA and is associated with impaired glucose metabolism, which could increase the risk of T2DM. PA itself seems to enhance insulin resistance.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gerards J, Heinrich DA, Adolf C, et al. Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion. J Clin Endocrinol Metab. 2019. PMID: 30865224. doi:10.1210/jc.2019-00299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。